Kanker Payudara

From Canvas to Chromosomes: Inside the Evolving World of Cancer Genomics with Chris Watt

• Genomics and Precision Medicine

From Canvas to Chromosomes: Inside the Evolving World of Cancer Genomics with Chris Watt

Neng Nana June 22, 2026

In the rapidly accelerating field of precision medicine, the role of the clinical scientist has never been...

Read More Read more about From Canvas to Chromosomes: Inside the Evolving World of Cancer Genomics with Chris Watt

Bionyra Emerges from Stealth with $165 Million to Challenge the Immunology "Efficacy Ceiling"

• Treatment Innovations

Bionyra Emerges from Stealth with $165 Million to Challenge the Immunology "Efficacy Ceiling"

Reynand Wu June 22, 2026

By Gwendolyn Wu Published June 22, 2026 In a significant move that underscores the pharmaceutical industry’s intensifying...

Read More Read more about Bionyra Emerges from Stealth with $165 Million to Challenge the Immunology "Efficacy Ceiling"

A New Frontier in Hematology: Teclistamab Redefines Treatment for High-Risk Smoldering Multiple Myeloma

• Clinical Oncology Education

A New Frontier in Hematology: Teclistamab Redefines Treatment for High-Risk Smoldering Multiple Myeloma

Nila Kartika Wati June 22, 2026

In a landmark development for the field of hematology, researchers from the Dana-Farber Cancer Institute have unveiled...

Read More Read more about A New Frontier in Hematology: Teclistamab Redefines Treatment for High-Risk Smoldering Multiple Myeloma

Beyond the Initial Impact: The Convergence of TBI and Alzheimer’s Research and the Promise of Next-Generation Immunotherapy

• Chemotherapy and Targeted Therapy

Beyond the Initial Impact: The Convergence of TBI and Alzheimer’s Research and the Promise of Next-Generation Immunotherapy

Neng Nana June 22, 2026

Traumatic Brain Injury (TBI) is often perceived as a singular event—a collision, a fall, or a strike....

Read More Read more about Beyond the Initial Impact: The Convergence of TBI and Alzheimer’s Research and the Promise of Next-Generation Immunotherapy

Recalculating: Navigating the Uncharted Territory of a Cancer Diagnosis

• Survivorship and Post-Treatment

Recalculating: Navigating the Uncharted Territory of a Cancer Diagnosis

Nila Kartika Wati June 22, 2026

By Investigative Health Desk April 16, 2026 The journey through a cancer diagnosis is rarely a straight...

Read More Read more about Recalculating: Navigating the Uncharted Territory of a Cancer Diagnosis

The Two-Decade Vigil: Shira Kolat’s Journey from Genetic Previvor to Triple-Negative Survivor

• Patient Advocacy and Support

The Two-Decade Vigil: Shira Kolat’s Journey from Genetic Previvor to Triple-Negative Survivor

Ali Ikhwan June 22, 2026

GAITHERSBURG, MD — For most people, a cancer diagnosis is a sudden, localized earthquake that shatters the...

Read More Read more about The Two-Decade Vigil: Shira Kolat’s Journey from Genetic Previvor to Triple-Negative Survivor

From Survival to Solidarity: How One Woman’s Journey Redefined Resilience and Community Care

• Integrative Oncology and Holistic Care

From Survival to Solidarity: How One Woman’s Journey Redefined Resilience and Community Care

Basiran June 22, 2026

For many, the concept of "living authentically" is an abstract ideal. For Johana, it has been a...

Read More Read more about From Survival to Solidarity: How One Woman’s Journey Redefined Resilience and Community Care

• Integrative Oncology and Holistic Care

Pevita Pearce June 22, 2026

Read More Read more about

Decoding the Canopy: How Genomics is Rewriting the Future of Forest Resilience

• Genomics and Precision Medicine

Decoding the Canopy: How Genomics is Rewriting the Future of Forest Resilience

Ali Ikhwan June 22, 2026

In the grand tapestry of the natural world, trees have long served as silent sentinels—witnesses to the...

Read More Read more about Decoding the Canopy: How Genomics is Rewriting the Future of Forest Resilience

Beyond PD-1: The New Frontier of Oncology at ASCO 2026

• Treatment Innovations

Beyond PD-1: The New Frontier of Oncology at ASCO 2026

Jia Lissa June 22, 2026

The global biotech sector is undergoing a profound transformation. After a period of cooling, the industry is...

Read More Read more about Beyond PD-1: The New Frontier of Oncology at ASCO 2026